Sebia’s Post

Still time to register for this Educational Webinar on A1c in relation with the updated Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus #sebia #HbA1c #capillarys #webinar

Great opportunity to catch up with the updated Guidelines and Recommendations for Laboratory Analysis in the #Diagnosis and Management of #Diabetes Mellitus.

This regulatory education conference opportunity is a great way to hear directly from the regulators. It's being offered in-person and virtually, and if you're unable to attend live, you can watch afterward as your schedule permits. I'm planning on virtually attending some sessions live and will catch up on others of interest later this week. #fda #regulatorycompliance

🔥 #Free 🔥registration is available for virtual attendance at the #FDA’s 2024 Regulatory Education for Industry (REdI) Conference on May 29 and 30 with multiple tracks for CDER, CDRH and CBER. #regulatory #training #education #lucentclinical

#CollectionSpotlight There has been an explosion of practice-changing GLP-1 research, and we have seen this reflected in the papers our users are reading. Therefore, we have created a cross-specialty collection that will be regularly updated with the latest GLP-1 research, curated by doctors from our review team, to ensure relevancy and reliability. https://lnkd.in/gtX_XH7s Follow the collection to be notified when new research is added. #GLP1 #ReadbyQxMD

That's a wrap - What a resounding market reaction to the Virta Health GLP Resource! "It was really well done. I downloaded it and am going to use it as a template for ongoing strategy “stuff” ... "I just wanted to say props on the document, it's nicely put together and very well-targeted." ... "I would love to get a link to your GLP-1 insights deck! I hear it's very well done!" ... "I especially like the questions to ensure alignment and the evaluation prompts." Excited to see where all these new and revised GLP strategies land in 2024 and 2025. #glp1s #glpstrategy #obesity #benefitsstrategy

I've previously detailed the lean mass consideration for GLP1s, but here is a refresher: 1️⃣ Functional health is not only preserved but improved in the GLP-1RA clinical trials: ⬆️ HRQoL, SF-36, KCCQ-CSS, and 6MWD 2️⃣ Resistance training can attenuate lean mass losses (Lundgren et al. 2021) https://lnkd.in/g5GDzTd7

💡 Find your way through the clew of regulations, guidelines and requirements? In 2dayRA (Oct 3rd and 4th) we explain how to untangle: let guidance improve and accelerate your drug development and obtain tailored authority advice! Check out the full 2dayRA program on Essentials of RA at www.az-regulatory.com. Register to the F2F course: highly interactive presentations as well as with typical practical cases. 

This two-day, in-person course is a great way to get an overview of #Regulatory Affairs! Who could benefit from this 2-day course? - Anyone new to Regulatory Affairs who wants an introduction, - Anyone experienced in Regulatory affairs who wants a refresher on current US & EU procedures, - Anyone in a related discipline looking to enhance their cross-functional knowledge in this important and wide-reaching topic: #Pharmacovigilance, #Quality, #Compliance, #ClinicalDevelopment #RegulatoryAffairs #Ausbildung #RegulatoryAffairsTraining

Revisions to the CLIA proficiency testing regulations go into effect on July 11, 2024. They include 29 newly regulated analytes and tighter proficiency testing acceptable limits for many currently regulated analytes, along with changes to grading and reporting. These revisions will drive updates to the proficiency testing conducted by laboratories. In this webinar, Dr. Bremansu Osa-Andrews discusses the upcoming changes and provides actionable steps laboratorians can take to prepare